American College of Toxicology

SITE MAP
About ACT
Meetings & Courses
Journal
Good Stuff
Members



= Members Only

Educational Courses

Practical Application of Toxicology in Drug Development

Co-Sponsored with Charles River and in association with the British Toxicology Society

Course Description

This course, taught by distinguished experts, is designed to provide a basic training in toxicology. Participants will obtain an overall understanding of the principles of nonclinical safety evaluation with emphasis on the practical application of these principles and interpretation of nonclinical safety data. The course will include discussion of regulatory case studies and a workshop. This toxicology course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, along with those from Contract Research Organizations and regulatory agencies who are interested in toxicology. Regulatory toxicology in drug development will be emphasized, particularly from the European perspective.

Course brochure
Course flyer

Course Schedule

Monday, September 9

Basic Principles of Toxicology, A. Wallace Hayes, Harvard
Toxicology Methods/General Tox, Adam Woolley, ForthTox
Pharmacokinetics/ADME, Gerry Kenna, Safety Science Consultant
Regulatory Toxicology, David Jones, MHRA

Tuesday, September 10

Organ Systems, Nigel Toseland, Consultant, University of Surrey
Clinical Pathology, Malcolm York, GlaxoSmithKline
Pathology, Peter Greaves, MRC Toxicology Unit

Wednesday, September 11

Genetic Toxicology, Veronique Thybaud, Sanofi
Carcinogenicity, Nigel Roome, Sanofi
Reproduction/Developmental Toxicology, Gary Chellman, Charles River
Immunotoxicology, Ian Kimber, University of Manchester

Thursday, September 12

Pharmacology, Rob Wallis, Safety Pharmacology Consultant
Safety Pharmacology, Rob Wallis, Safety Pharmacology Consultant
Safety of Biotechnology Products, Jennifer Sims, Integrated Biologics
Risk Assessment, Ernie Harpur, Newcastle University
Regulatory Case Studies, TBD

Friday, September 13

Nonclinical Assessment of Drug A:
A Special Workshop of Drug Development from Regulatory Perspective,

Kenneth Hastings, Sanofi
Timothy McGovern, SciLucent
Tracey Zoetis, SciLucent
David Jones, MHRA
Per Sjoberg, Eureda

Times

Monday through Thursday¬† 8:00 AM–5:00 PM

Friday 8:00 AM–12:00 Noon

Program Committee:
Ernie Harpur, Newcastle University
Hanan Ghantous, US FDA
Norman Kim, Biogen Idec

Organizer:
Karen McCusker, Charles River

Registration

Register online
Registration form

Space is limited to 60 attendees—register early

ACT and BTS Member Registration £575
Nonmember Registration £875
Government Registration £575
Group Nonmember Registration
(Three or More from Same Organization*)
£575
Group Member Registration
(Three or More from Same Organization*)
£375

* In order to take advantage of this discounted rate, registration form(s) should be returned to ACT Headquarters for processing.

Note: Payments will be processed in US $.

Refund Policy:

  • £50 Processing Fee will be charged before June 28, 2013.
  • 50% refund if canceled before July 26, 2013.
  • After July 26, 2013, no fees will be refunded.

Location

The course is held at the Edinburgh Capital Hotel
187 Clermiston Road
Edinburgh EH 12 6UG
United Kingdom
www.edinburghcapitalhotel.co.uk
+44(0)131.535.9988

For lodging, make arrangements directly with the hotel above, mentioning that you are participating in the course.

Housing Deadline: Monday, August 12


















Join or Renew ACT membership
2019 Annual Meeting
ACT
11190 Sunrise Valley Drive, Suite 300, Reston, Virginia 20191
Tel: 703.547.0875 | Fax: 703.438.3113 | Email: acthq@actox.org


Copyright © 2019 American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | Provide Consent | Unsubscribe